Euvipharm

Long An, Vietnam Founded: 2005 • Age: 21 yrs Acquired By JW Pharmaceutical
Pharmaceutical ingredients and formulations are manufactured under contract.

About Euvipharm

Euvipharm is a Healthcare company based in Vietnam founded in 2005, and was acquired by JW Pharmaceutical in September 2019. Pharmaceutical ingredients and formulations are manufactured under contract. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides.

Company details

Euvipharm was established in 2005 in Long An, Vietnam, within the pharmaceutical sector. Contract manufacturing services are provided for active pharmaceutical ingredients and finished formulations. Operations are centered on production processes that meet industry standards, supporting clients in developing and supplying medicinal products. The companys location facilitates regional distribution in Southeast Asia.

Key Metrics

Investors in Euvipharm

Euvipharm has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Bausch Health, JW Pharmaceutical and Công ty CP Dược phẩm Cửu Long.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Pharmaceutical products and medical devices are developed and manufactured.
1945jw-pharma.co.krSeoul, South Korea
pharimexco.com.vn
Therapeutics for multiple diseases including dermatology and neurology are developed.
1960bauschhealth.comLaval, Canada
Premium access

Investor details for Euvipharm

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Euvipharm

4 dated milestones of Euvipharm across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded Euvipharm is founded.
  2. Exit Acquired by Bausch Health.
  3. Exit Acquired by Công ty CP Dược phẩm Cá»­u Long.
  4. Exit Acquired by JW Pharmaceutical.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Euvipharm

Premium access

Complete news archive for Euvipharm

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Euvipharm

Euvipharm was founded in 2005.

Euvipharm is headquartered in Vietnam. It is registered at Long An, Vietnam.

Euvipharm was established in 2005 in Long An, Vietnam, within the pharmaceutical sector. Contract manufacturing services are provided for active pharmaceutical ingredients and finished formulations. Operations are centered on production processes that meet industry standards, supporting clients in developing and supplying medicinal products. The companys location facilitates regional distribution in Southeast Asia.

Euvipharm has 3 investors. Key investors include Bausch Health, JW Pharmaceutical, and Công ty CP Dược phẩm Cửu Long.

Yes. Euvipharm was acquired by JW Pharmaceutical in September 2019.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available